Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Boston Scientific Closes Acquisition of Axonics, Inc.
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
Axonics Modulation Technologies (AXNX) Surpasses Q2 Earnings and Revenue Estimates
Axonics, Inc. (NASDAQ:AXNX) Shares Sold by Amalgamated Bank
Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia
Axonics Reports First Quarter 2024 Financial Results
Boston Scientific Announces Results for First Quarter 2024
FTC seeks more information on Boston Scientific's $3.7 bln Axonics deal
All You Need to Know About Axonics (AXNX) Rating Upgrade to Buy
Axonics Stockholders Approve Merger Agreement with Boston Scientific
Axonics Provides Update on Inter Partes Review Proceedings
Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
Axonics Responds to ITC Action by Medtronic
Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass Estimates
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
4 Stocks Backed by High Efficiency to Enrich Your Portfolio
Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX
Why Axonics Stock Soared Today
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Axonics, Inc.
Why Is Axonics (AXNX) Stock Up 20% Today?
Axonix Stock Hits 52-Week High on Buyout Buzz
Shareholder Alert: Ademi LLP investigates whether Axonics, Inc. has obtained a Fair Price in its transaction with Boston Scientific
AXNX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Axonics, Inc. Is Fair to Shareholders
Axonics Stock Soars. It's Being Acquired By Boston Scientific In $3.7 Billion Deal.
Boston Scientific To Acquire Axonics For About $3.7 Bln
Boston Scientific to buy Axonics for $3.7 billion
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Axonics Announces Definitive Agreement to be Acquired by Boston Scientific
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
Axonics to Present at the J.P. Morgan Healthcare Conference
BiVACOR Appoints Veteran Medical Device Executive Raymond W. Cohen as Chairman of the Board of Directors
Buy These 4 Low-Beta Stocks to Counter Market Volatility
Goldman Sachs money manager digs into three themes for long-term growth
3 Stocks Backed by High Efficiency to Increase Portfolio Returns
Wall Street Analysts Believe Axonics (AXNX) Could Rally 25.1%: Here's is How to Trade
Axonics to Participate in November Investor Conferences
New Strong Buy Stocks for October 31st
Axonics, Inc. (AXNX) Q3 2023 Earnings Call Transcript
Axonics Modulation Technologies (AXNX) Q3 Earnings and Revenues Top Estimates
Axonics Reports Third Quarter 2023 Financial Results
5 Top Stocks Set to Beat Q3 Earnings Estimates on Monday
Axonics Modulation Technologies (AXNX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Axonics to Report Third Quarter 2023 Financial Results on October 30